Metaproterenol Sulfate
NDC Package 49502-678-24

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Metaproterenol Sulfate is metaproterenol is used to treat wheezing and shortness of breath from lung problems (e.g., asthma, chronic obstructive pulmonary disease, bronchitis, emphysema). Marketed by Mylan Specialty L.p., this product is identified by NDC 49502-678 and is authorized under FDA application ANDA071786.

Identification & Billing

NDC Package Code
49502-678-24
Package Description
5 POUCH in 1 CARTON / 5 VIAL in 1 POUCH / 2.5 mL in 1 VIAL
Product Code
49502-678
11-Digit Billing Format
49502067824

Clinical Specifications

Proprietary Name
Metaproterenol Sulfate
Dosage Form
-
Usage Information
Metaproterenol is used to treat wheezing and shortness of breath from lung problems (e.g., asthma, chronic obstructive pulmonary disease, bronchitis, emphysema). Controlling these symptoms can decrease time lost from work or school. Metaproterenol belongs to a class of drugs known as bronchodilators. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. This drug is also known as orciprenaline in other countries.

Regulatory & Marketing

Labeler Name
Mylan Specialty L.p.
FDA Application #
ANDA071786
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
05-30-2009
End Marketing Date
05-31-2009
Listing Expiration
05-31-2009
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 49502-678-24 identifies a specific commercial package of 5 pouch in 1 carton / 5 vial in 1 pouch / 2.5 ml in 1 vial of Metaproterenol Sulfate, labeled by Mylan Specialty L.p.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Mylan Specialty L.p. on May 30, 2009. The current certification is valid through May 31, 2009.

What are the primary indications for this medication?

Metaproterenol is used to treat wheezing and shortness of breath from lung problems (e.g., asthma, chronic obstructive pulmonary disease, bronchitis, emphysema). Controlling these symptoms can decrease time lost from work or school. Metaproterenol belongs to a class of drugs known as bronchodilators. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. This drug is also known as orciprenaline in other countries.

How is this Mylan Specialty L.p. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 49502067824. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
49502-678-24
11-Digit CMS (5-4-2)
49502-0678-24

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.